Emory Center for Preventing Injuries, Overdose, and Violence

CE24-001, Injury Prevention Research Center at Emory (IPRCE).

NIH-funded research Emory University · NIH-11163194

This center partners with pharmacies, community groups, hospitals, and peer networks to get overdose-reversal tools, suicide-prevention support, and trauma-informed care to people and communities most at risk.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionEmory University NIH-funded
Lab location1 site (Atlanta, United States)
Project IDNIH-11163194 on NIH RePORTER

What this research studies

At Emory, researchers and community partners work together to expand access to naloxone and fentanyl test strips through pharmacies and harm-reduction organizations and to strengthen peer networks that support people at risk of overdose. They are developing and piloting suicide-prevention approaches tailored for Black men who have access to firearms and studying risk and protective factors that matter for these men. The center is also creating and testing strategies to help hospitals and community programs deliver trauma-informed care for youth who survive violent injury. Throughout, teams use implementation science, community feedback, and training to find practical ways to make proven tools reach more people.

Who could benefit from this research

Good fit: People who might take part include individuals at risk of opioid overdose, community members served by harm-reduction programs or pharmacies, Black men with access to firearms, and youth recovering from violent injury or their caregivers.

Not a fit: People without risk factors for overdose, violence, or suicide or those living outside the programs' service areas may not get direct benefit from these specific activities.

Why it matters

Potential benefit: If successful, this work could make life-saving overdose tools and tailored prevention and recovery services more available, lowering deaths and improving recovery in affected communities.

How similar studies have performed: Prior work shows naloxone distribution and harm-reduction programs can reduce overdose deaths and that trauma-informed approaches can aid recovery, but adapting these strategies to pharmacies, firearm-access populations, and hospital-community systems is relatively new.

Where this research is happening

Atlanta, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.